Cel-Sci
CVM
#9783
Rank
NZ$86.69 M
Marketcap
NZ$10.85
Share price
-2.79%
Change (1 day)
-67.02%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$23.02 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are NZ$23.02 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30NZ$22.26 M-22.92%
2023-09-30NZ$28.87 M-11.34%
2022-09-30NZ$32.57 M16.18%
2021-09-30NZ$28.03 M-10.78%
2020-09-30NZ$31.42 M-12.5%
2019-09-30NZ$35.91 M-19.6%
2018-09-30NZ$44.66 M22.32%
2017-09-30NZ$36.51 M3.7%
2016-09-30NZ$35.21 M-32.47%
2015-09-30NZ$52.14 M363.41%
2014-09-30NZ$11.25 M125.55%
2013-09-30NZ$4.98 M-54.32%
2012-09-30NZ$10.92 M-12.21%
2011-09-30NZ$12.43 M-8.27%
2010-09-30NZ$13.56 M-73.98%
2009-09-30NZ$52.11 M812.01%
2008-09-30NZ$5.71 M-27.75%
2007-09-30NZ$7.9 M-51.23%
2006-09-30NZ$16.21 M1034.48%
2005-09-30NZ$1.42 M-30.99%
2004-09-30NZ$2.07 M-27.52%
2003-09-30NZ$2.85 M-50.33%
2002-09-30NZ$5.75 M361.1%
2001-09-30NZ$1.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
NZ$73.22 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.44 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$139.28 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.42 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.39 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$196.39 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.51 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$4.5 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA